Search Result "Expression of Apo2L/TRAIL"
APO2L/TRAIL: New Insights in the Treatment of Autoimmune Disorders
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 5 Issue: 3 Year: 2011 Page: 184-199
Author(s): Alberto Anel, Luis Martinez-Lostao
TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 7 Year: 2005 Page: 933-944
Author(s): G. Fiorucci, S. Vannucchi, Maria V. Chiantore, Zulema A. Percario, E. Affabris, G. Romeo
Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 3 Year: 2011 Page: 311-323
Author(s): Sarah Shirley, Alexandre Morizot, Olivier Micheau
Targeting Trail Towards the Clinic
Journal: Current Drug Targets
Volume: 12 Issue: 1 Year: 2011 Page: 2079-2090
Author(s): Devalingam Mahalingam, Corina N.A.M. Oldenhuis, Eva Szegezdi, Francis J. Giles, Elisabeth G.E. de Vries, Steven de Jong, Steffan T. Nawrocki
TRAIL Receptor-Induced Cell Death Regulation: An Update to Our Deadly Discussion
Ebook: Topics in Anti-Cancer Research
Volume: 3 Year: 2014
Author(s): Olivier Micheau,Sarah Shirley,Alexandre Morizot
Doi: 10.2174/9781608059089114030004
Kaempferol Improves TRAIL-Mediated Apoptosis in Leukemia MOLT-4 Cells by the Inhibition of Anti-apoptotic Proteins and Promotion of Death Receptors Expression
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 19 Issue: 15 Year: 2019 Page: 1835-1845
Author(s): Ali Hassanzadeh,Adel Naimi,Majid F. Hagh,Raedeh Saraei,Faroogh Marofi,Saeed Solali
Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3 Issue: 5 Year: 2003 Page: 334-342
Author(s): Patrizia Marini, Claus Belka
Death Receptors as Targets of Cancer Therapeutics
Journal: Current Cancer Drug Targets
Volume: 4 Issue: 1 Year: 2004 Page: 97-104
Author(s): M. Saeed Sheikh, Ying Huang
Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 2 Year: 2008 Page: 124-131
Author(s): D. Daniel, N. S. Wilson
Use of Systemic Proteasome Inhibition as an Immune-Modulating Agent in Disease
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 7 Issue: 1 Year: 2007 Page: 29-34
Author(s): Lauren H. Mattingly, Ruth A. Gault, William J. Murphy